205 related articles for article (PubMed ID: 33335784)
1. Clonally Related Plasmablastic Lymphoma Simultaneously Occurring with Diffuse Large B-Cell Lymphoma.
Hashimoto N; Ueda T; Hiraiwa S; Tajiri T; Nakamura N; Yokoyama K
Case Rep Hematol; 2020; 2020():8876567. PubMed ID: 33335784
[TBL] [Abstract][Full Text] [Related]
2. Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review.
Cao C; Liu T; Lou S; Liu W; Shen K; Xiang B
Oncol Lett; 2014 Dec; 8(6):2539-2542. PubMed ID: 25364423
[TBL] [Abstract][Full Text] [Related]
3. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
Morley AM; Verity DH; Meligonis G; Rose GE
Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
[TBL] [Abstract][Full Text] [Related]
5. An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen.
Nelson B; Hong A; Iqbal F; Venkatesan R
Cureus; 2020 Jun; 12(6):e8641. PubMed ID: 32685310
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.
Elyamany G; Al Mussaed E; Alzahrani AM
Adv Hematol; 2015; 2015():315289. PubMed ID: 26357515
[TBL] [Abstract][Full Text] [Related]
7. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D; Nagpal S; Lechowicz MJ; Gaur R; Lucas A; Melani C; Roschewski M; Steinberg SM; Jaffe ES; Kahl B; Friedberg JW; Little RF; Bartlett NL; Wilson WH
Lancet Haematol; 2018 Dec; 5(12):e609-e617. PubMed ID: 30501868
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications.
Mansoor A; Akhter A; Kamran H; Minoo P; Stewart D
Hum Pathol; 2023 Nov; 141():102-109. PubMed ID: 37524252
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic Lymphoma of Small Intestine: A Rare Case Report with Review of Literature.
Khera R; Ahmed F; Murthy SS; Mallavarapu KM
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):130-4. PubMed ID: 27408374
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea.
Kim JE; Kim YA; Kim WY; Kim CW; Ko YH; Lee GK; Choi SJ; Jeon YK
Leuk Lymphoma; 2009 Apr; 50(4):582-7. PubMed ID: 19373656
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic lymphoma in HIV patients: Experience at a tertiary care hospital in eastern India.
Bishnu S; Banerjee S; Bandyopadhyay D; Samui S; Bhattacharya S; Bose D
Indian J Cancer; 2015; 52(4):563-7. PubMed ID: 26960478
[TBL] [Abstract][Full Text] [Related]
12. CD-20 Negative Plasmablastic Lymphoma Lurking in the Shadow of a Leiomyoma - Diagnosis and Management.
Bindra BS; Ramineni G; Sattar Y; Khillan R
Cureus; 2019 Jul; 11(7):e5217. PubMed ID: 31565620
[TBL] [Abstract][Full Text] [Related]
13. Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.
Ise M; Kageyama H; Ikebe D; Araki A; Kumagai K; Itami M
J Clin Exp Hematop; 2018 Sep; 58(3):128-135. PubMed ID: 30012920
[TBL] [Abstract][Full Text] [Related]
14. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.
Xu J; Liu JL; Medeiros LJ; Huang W; Khoury JD; McDonnell TJ; Tang G; Schlette E; Yin CC; Bueso-Ramos CE; Lin P; Li S
Eur J Haematol; 2020 Apr; 104(4):336-343. PubMed ID: 31944390
[TBL] [Abstract][Full Text] [Related]
15. Plasmablastic Lymphoma Mimicking Acute Pancreatitis.
Inayat F; Virk HU; Cheema AR; Saif MW
Case Rep Oncol Med; 2016; 2016():9751736. PubMed ID: 27034868
[TBL] [Abstract][Full Text] [Related]
16. Plasmablastic lymphoma of the stomach in an HIV-negative patient.
Hashimoto M; Inaguma S; Kasai K; Kuwabara K; Noda N; Hayakawa M; Fujino M; Ito M; Ikeda H
Pathol Int; 2012 Nov; 62(11):763-70. PubMed ID: 23121609
[TBL] [Abstract][Full Text] [Related]
17. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
Castillo J; Pantanowitz L; Dezube BJ
Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
Akyurek N; Uner A; Benekli M; Barista I
Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
[TBL] [Abstract][Full Text] [Related]
20. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
Bibas M
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]